Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

PRP more effective than minoxidil 5% for treating alopecia areata.

Both mouse and rat models are effective for testing alopecia areata treatments.

The mouse hairy ears mutation causes longer ear hair due to changes in gene expression.

Hair proteins in preschool children and their mothers could indicate developmental changes and health status.

Researchers made a mouse model with curly hair and hair loss by editing a gene.

Advancements in tissue engineering show promise for hair follicle regeneration to treat hair loss.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Mice with a mutated Dsg3 gene showed severe symptoms but not the typical blistering of pemphigus vulgaris.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Astragaloside IV may help prevent hair loss by blocking a specific pathway that leads to cell death.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Colored hair-thickening fibers can help hide hair loss in some people with Epidermolysis Bullosa but may cause scalp irritation.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Immune cells affect hair growth and could lead to new hair loss treatments.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Glucocorticoids for progressive muscular dystrophy in children don't improve muscle strength or function but do increase certain side effects.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.